MiRNA-202 Role in Reproductive System and Gynecological Cancers

O’Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402.

Article  CAS  Google Scholar 

Khan HL, Bhatti S, Abbas S, Kaloglu C, Isa AM, Younas H, et al. Extracellular microRNAs: key players to explore the outcomes of in vitro fertilization. Reprod Biol Endocrinol. 2021;19(1):1–17.

Article  Google Scholar 

Santamaria X, Taylor H. MicroRNA and gynecological reproductive diseases. Fertil Steril. 2014;101(6):1545–51.

Article  CAS  PubMed  Google Scholar 

Brunetti M, Panagopoulos I, Vitelli V, Andersen K, Hveem TS, Davidson B, et al. Endometrial carcinoma: molecular cytogenetics and transcriptomic profile. Cancers. 2022;14(14):3536.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monk BJ, Tan DS, Chagüi JDH, Takyar J, Paskow MJ, Nunes AT, et al. Proportions and incidence of locally advanced cervical cancer: a global systematic literature review. Int J Gynecol Cancer. 2022. https://doi.org/10.1136/ijgc-2022-003801.

Article  PubMed  PubMed Central  Google Scholar 

Zhu JW, Charkhchi P, Akbari MR. Potential clinical utility of liquid biopsies in ovarian cancer. Mol Cancer. 2022;21(1):1–24.

Article  CAS  Google Scholar 

Zhang D, Wang L, Guo HL, Zhang ZW, Wang C, Chian RC, et al. MicroRNA-202 inhibits endometrial stromal cell migration and invasion by suppressing the K-Ras/Raf1/MEK/ERK signaling pathway. Int J Mol Med. 2020;46(6):2078–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Y, Xie L, Xu S, Yan W, Zhang H, Meng Y, et al. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial–mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Mol Cell Biochem. 2021;476(11):4031–44.

Article  CAS  PubMed  Google Scholar 

Yi Y, Li H, Lv Q, Wu K, Zhang W, Zhang J, et al. miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1. Oncotarget. 2016;7(44):72067.

Article  PubMed  PubMed Central  Google Scholar 

Deng X, Hou C, Liang Z, Wang H, Zhu L, Xu H. miR-202 suppresses cell proliferation by targeting FOXR2 in endometrial adenocarcinoma. Dis mark. 2017. https://doi.org/10.1155/2017/2827435.

Article  Google Scholar 

Zhang M, Zhang Y, Li L, Ma L, Zhou C. Dysregulation of miR-202-3p affects migration and invasion of endometrial stromal cells in endometriosis via targeting ROCK1. Reprod Sci. 2020;27(2):731–42.

Article  CAS  PubMed  Google Scholar 

Fassina A, Cappellesso R, Fassan M. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest. 2011;140(5):1305–11.

Article  CAS  PubMed  Google Scholar 

Yu H, Pan S. MiR-202-5p suppressed cell proliferation, migration and invasion in ovarian cancer via regulating HOXB2. Eur Rev Med Pharmacol Sci. 2020;24:2256–63.

PubMed  Google Scholar 

Mallender WD, Yager D, Onstead L, Nichols MR, Eckman C, Sambamurti K, et al. Characterization of recombinant, soluble β-secretase from an insect cell expression system. Mol Pharmacol. 2001;59(3):619–26.

Article  CAS  PubMed  Google Scholar 

Wahid F, Shehzad A, Khan T. Kim YY 2010 MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochimica et Biophysica Acta (BBA)-Molecular Cell Res. 1803;11:1231–43.

Google Scholar 

Melamed ZE, Levy A, Ashwal-Fluss R, Lev-Maor G, Mekahel K, Atias N, et al. Alternative splicing regulates biogenesis of miRNAs located across exon-intron junctions. Mol cell. 2013;50(6):869–81.

Article  CAS  PubMed  Google Scholar 

Hoffman AE, Liu R, Fu A, Zheng T, Slack F, Zhu Y. Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesismiR-202 and lymphomagenesis. Cancer Epidemiol Biomark Prev. 2013;22(3):327–36.

Article  CAS  Google Scholar 

Bizuayehu TT, Babiak I. MicroRNA in teleost fish. Genome Biol Evol. 2014;6(8):1911–37.

Article  PubMed  PubMed Central  Google Scholar 

Di Fiore R, Suleiman S, Pentimalli F, O’toole SA, O’leary JJ, Ward MP, et al. Could MicroRNAs be useful tools to improve the diagnosis and treatment of rare gynecological cancers? A brief overview. Int j mol sci. 2021;22(8):3822.

Article  PubMed  PubMed Central  Google Scholar 

Wongwarangkana C, Fujimori KE, Akiba M, Kinoshita S, Teruya M, Nezuo M, et al. Deep sequencing, profiling and detailed annotation of microRNAs in Takifugu rubripes. BMC Genomics. 2015;16(1):1–14.

Article  CAS  Google Scholar 

Rosa A, Brivanlou AH. Regulatory non-coding RNAs in pluripotent stem cells. Int J Mol Sci. 2013;14(7):14346–73.

Article  PubMed  PubMed Central  Google Scholar 

Ahmed EA, Rajendran P, Scherthan H. The microRNA-202 as a diagnostic biomarker and a potential tumor suppressor. Int J Mol Sci. 2022;23(11):5870.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hashemipour M, Boroumand H, Mollazadeh S, Tajiknia V, Nourollahzadeh Z, Borj MR, et al. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecol Oncol. 2021;161(1):314–27.

Article  CAS  PubMed  Google Scholar 

Ledford LR, Lockwood S, editors. Scope and epidemiology of gynecologic cancers: an overview. Seminars in oncology nursing; 2019: Elsevier.

Mills AM, Bullock TN, Ring KL. Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologists. Mod Pathol. 2022;35(2):142–51.

Article  CAS  PubMed  Google Scholar 

Razavi ZS, Tajiknia V, Majidi S, Ghandali M, Mirzaei HR, Rahimian N, et al. Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles. Crit Rev Oncol Hematol. 2021;157: 103192.

Article  PubMed  Google Scholar 

Wang Q, Peng H, Qi X, Wu M, Zhao X. Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence. Signal Transduct Target Ther. 2020;5(1):137.

Article  PubMed  PubMed Central  Google Scholar 

Gonçalves V. Long-term quality of life in gynecological cancer survivors. Curr Opin Obstet Gynecol. 2010;22(1):30–5.

Article  PubMed  Google Scholar 

Crusz SM, Miller RE. Targeted therapies in gynaecological cancers. Histopathology. 2020;76(1):157–70.

Article  PubMed  Google Scholar 

De Almeida BC, Garcia N, Maffazioli G, Gonzalez dos Anjos L, ChadaBaracat E, CandidoCarvalho K. Oncomirs expression profiling in uterine leiomyosarcoma cells. Int j mol sci. 2017;19(1):52.

Article  PubMed  PubMed Central  Google Scholar 

Kim J, Park S, Hwang D, Kim SI, Lee H. Diagnostic value of circulating miR-202 in early-stage breast cancer in South Korea. Medicina. 2020;56(7):340.

Article  PubMed  PubMed Central  Google Scholar 

Zheng Y, Xie L, Xu S, Yan W, Zhang H, Meng Y, et al. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial–mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Mol Cell Biochem. 2021;476:4031–44.

Article  CAS  PubMed  Google Scholar 

Chang RK, Li X, Mu N, Hrydziuszko O, Garcia-Majano B, Larsson C, et al. MicroRNA expression profiles in non-epithelial ovarian tumors. Int J Oncol. 2018;52(1):55–66.

CAS  PubMed  Google Scholar 

Yu H, Pan S. MiR-202–5p suppressed cell proliferatio

Comments (0)

No login
gif